TY - JOUR
T1 - Genetic associations with plasma B12, B6, and folate levels in an ischemic stroke population from the vitamin intervention for stroke prevention (VISP) trial
AU - on behalf of the GARNET Collaborative Research Group
AU - Keene, Keith L.
AU - Chen, Wei Min
AU - Chen, Fang
AU - Williams, Stephen R.
AU - Elkhatib, Stacey D.
AU - Hsu, Fang Chi
AU - Mychaleckyj, Josyf C.
AU - Doheny, Kimberly F.
AU - Pugh, Elizabeth W.
AU - Ling, Hua
AU - Laurie, Cathy C.
AU - Gogarten, Stephanie M.
AU - Madden, Ebony B.
AU - Worrall, Bradford B.
AU - Sale, Michele M.
N1 - Publisher Copyright:
© 2014 Keene, Chen, Chen, Williams, Elkhatib, Hsu, Mychaleckyj, Doheny, Pugh, Ling, Laurie, Gogarten, Madden, Worrall and Sale on behalf of the GARNET Collaborative Research Group.
PY - 2014/8/6
Y1 - 2014/8/6
N2 - Background: B vitamins play an important role in homocysteine metabolism, with vitamin deficiencies resulting in increased levels of homocysteine and increased risk for stroke. We performed a genome-wide association study (GWAS) in 2,100 stroke patients from the Vitamin Intervention for Stroke Prevention (VISP) trial, a clinical trial designed to determine whether the daily intake of high-dose folic acid, vitamins B6, and B12 reduce recurrent cerebral infarction. Methods: Extensive quality control (QC) measures resulted in a total of 737,081 SNPs for analysis. Genome-wide association analyses for baseline quantitative measures of folate, Vitamins B12, and B6 were completed using linear regression approaches, implemented in PLINK. Results: Six associations met or exceeded genome-wide significance (P = 5 × 10-08). For baseline Vitamin B12, the strongest association was observed with a non-synonymous SNP (nsSNP) located in the CUBN gene (P = 1.76 × 10-13). Two additional CUBN intronic SNPs demonstrated strong associations with B12 (P = 2.92× 10-10 and 4.11 × 10-10), while a second nsSNP located in the TCN1 gene, also reached genome-wide significance (P = 5.14 × 10-11). For baseline measures of Vitamin B6, we identified genome-wide significant associations for SNPs at the ALPL locus (rs1697421; P = 706 × 10-10 and rs1780316; P = 2.25 × 10-08). In addition to the six genome-wide significant associations, nine SNPs (two for Vitamin B6, six for Vitamin B12, and one for folate measures) provided suggestive evidence for association (P = 10-07). Conclusion: Our GWAS study has identified six genome-wide significant associations, nine suggestive associations, and successfully replicated 5 of 16 SNPs previously reported to be associated with measures of B vitamins. The six genome-wide significant associations are located in gene regions that have shown previous associations with measures of B vitamins; however, four of the nine suggestive associations represent novel finding and warrant further investigation in additional populations.
AB - Background: B vitamins play an important role in homocysteine metabolism, with vitamin deficiencies resulting in increased levels of homocysteine and increased risk for stroke. We performed a genome-wide association study (GWAS) in 2,100 stroke patients from the Vitamin Intervention for Stroke Prevention (VISP) trial, a clinical trial designed to determine whether the daily intake of high-dose folic acid, vitamins B6, and B12 reduce recurrent cerebral infarction. Methods: Extensive quality control (QC) measures resulted in a total of 737,081 SNPs for analysis. Genome-wide association analyses for baseline quantitative measures of folate, Vitamins B12, and B6 were completed using linear regression approaches, implemented in PLINK. Results: Six associations met or exceeded genome-wide significance (P = 5 × 10-08). For baseline Vitamin B12, the strongest association was observed with a non-synonymous SNP (nsSNP) located in the CUBN gene (P = 1.76 × 10-13). Two additional CUBN intronic SNPs demonstrated strong associations with B12 (P = 2.92× 10-10 and 4.11 × 10-10), while a second nsSNP located in the TCN1 gene, also reached genome-wide significance (P = 5.14 × 10-11). For baseline measures of Vitamin B6, we identified genome-wide significant associations for SNPs at the ALPL locus (rs1697421; P = 706 × 10-10 and rs1780316; P = 2.25 × 10-08). In addition to the six genome-wide significant associations, nine SNPs (two for Vitamin B6, six for Vitamin B12, and one for folate measures) provided suggestive evidence for association (P = 10-07). Conclusion: Our GWAS study has identified six genome-wide significant associations, nine suggestive associations, and successfully replicated 5 of 16 SNPs previously reported to be associated with measures of B vitamins. The six genome-wide significant associations are located in gene regions that have shown previous associations with measures of B vitamins; however, four of the nine suggestive associations represent novel finding and warrant further investigation in additional populations.
KW - Association
KW - B12
KW - B6
KW - Folate
KW - GWAS
KW - One-carbon metabolism
KW - VISP
UR - http://www.scopus.com/inward/record.url?scp=85017153592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85017153592&partnerID=8YFLogxK
U2 - 10.3389/fpubh.2014.00112
DO - 10.3389/fpubh.2014.00112
M3 - Article
AN - SCOPUS:85017153592
SN - 2296-2565
VL - 2
JO - Frontiers in Public Health
JF - Frontiers in Public Health
IS - AUG
M1 - 112
ER -